Publications by authors named "J R Fontenla"

Gamma-decanolactone (GD) is a monoterpene compound with anticonvulsant, antiparkinsonian, and neuroprotective effects in preclinical trials. This study aimed to evaluate the toxicity and antioxidant profile of GD in silico and in the Caenorhabditis elegans (C. elegans) experimental model.

View Article and Find Full Text PDF
Article Synopsis
  • "Marcela," a plant used in Brazilian traditional medicine, is investigated for its effects on Sars-Cov-2 symptoms and its toxicity profile through aqueous extract (ASAE) testing.
  • The study assessed various aspects like survival and reproduction of an alternative model, showing that ASAE at common human-use concentrations didn't significantly reduce worm survival.
  • ASAE demonstrated protective effects against oxidative damage and activated stress response pathways, suggesting it has a favorable toxicity profile for potential human use.
View Article and Find Full Text PDF

Psychiatric and neurological disorders affect millions of people worldwide. Currently available treatments may help to improve symptoms, but they cannot cure the diseases. Therefore, there is an urgent need for potent and safe therapeutic solutions.

View Article and Find Full Text PDF

Treatment of Parkinson's disease (PD) includes the use of monoamine oxidase-B (MAO-B) inhibitor drugs. In this work we have evaluated the possible gamma-decanolactone (GD) effect in vitro to inhibit the A and B isoforms of human monoamine oxidase (hMAO) enzyme and their citotoxicity in human hepatoma cell line (HepG2). Also, binding studies to A, A A and A adenosine receptors were performed.

View Article and Find Full Text PDF

The 3-pyridazinylcoumarin scaffold was previously reported as an efficient core for the discovery of reversible and selective inhibitors of MAO-B, a validated drug target for PD therapy which also plays an important role in the AD progress. Looking for its structural optimization, novel compounds of hybrid structure coumarin-pyridazine, differing in polarizability and lipophilicity properties, were synthesized and tested against the two MAO isoforms, MAO-A and MAO-B (compounds 17a-f and 18a-f). All the designed compounds selectively inhibited the MAO-B isoenzyme, exhibiting many of them IC values ranging from sub-micromolar to nanomolar grade and lacking neuronal toxicity.

View Article and Find Full Text PDF